Spain· ES:1201441002
BEMRIST BREEZHALER 125 microgramos/62,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)
A medicinal product containing indacaterol + mometasona, registered in Spain by Novartis Europharm Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- indacaterol + mometasona
- Manufacturer
- Novartis Europharm Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo72987730EUR 41.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol + mometasona in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATECTURA BREEZHALERNovartis Europharm Limited, Dublin
- FinlandAtectura BreezhalerNovartis Europharm Limited
- PolandAtectura BreezhalerNovartis Europharm Limited
- SwedenAtectura Breezhaler 125 mikrogram/127,5 mikrogram Inhalationspulver, hård kapselNovartis Europharm Limited
- SwitzerlandAtectura Breezhaler
- IrelandAtectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsulesNovartis Europharm Limited
- IcelandAtectura BreezhalerNovartis Europharm Limited*
- United KingdomAtectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with deviceNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Atectura Breezhaler, Bemrist Breezhaler
- Liechtenstein · Atectura Breezhaler, Bemrist Breezhaler
- Norway · Atectura Breezhaler, Bemrist Breezhaler
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7f0959f-907d-4066-a6a1-7b0bf243c93e GET /v1/drugs/b7f0959f-907d-4066-a6a1-7b0bf243c93e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1608131276000}",
"nregistro": "1201441002",
"substance": "indacaterol + mometasona"
}See everything about indacaterol + mometasona.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.